Bnp Paribas Asset Management Holding S.A. Arvinas, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Arvinas, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 743 shares of ARVN stock, worth $7,221. This represents 0.0% of its overall portfolio holdings.
Number of Shares
743Holding current value
$7,221% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
68.4MCall Options Held
2.99MPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA9.39MShares$91.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$60.8 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.67MShares$35.7 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA3.3MShares$32.1 Million3.14% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.15MShares$20.9 Million0.01% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $517M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...